New FDA Clearance fo...
Enhanced BIOFIRE®...
1st April 2019 Content supplied by: bioMérieux (Clinical Diagnostics)
Spotlight on Antimicrobial Stewardship with bioMérieux
Future generations need us to sustain antimicrobial efficacy and curb resistance – and appropriate use of antibiotics is key. Diagnostics play an essential role by providing actionable information to support decisions for antibiotic initiation, optimization and discontinuation.
To make the strongest impact possible, bioMérieux is committed to helping labs and healthcare professionals further improve antimicrobial stewardship. Here are a few highlights of what we have waiting for you at ECCMID:
At Stand No. #1.3
Some recent innovations:
- VITEK® 2 OPUS AST CARDS: One-card efficiency. More actionable results
- BIOFIRE® FILMARRAY® Pneumonia plus: Don’t let pneumonia bugs sneak by undetected!
- PhenoMATRIX™: Embedded interpretation intelligence for WASPLab®
At bioMérieux’s Integrated Symposium
Sunday, April 14 • 16:00-18:00 • Hall G
- With our expert speakers, explore the vital role of diagnostics in antimicrobial stewardship
Tags:
Date Published: 1st April 2019
New FDA Clearance for VITEK&
Enhanced BIOFIRE® Blood Culture
bioMérieux (Clinical Diagnostics)
Address:
Marcy L'Etoile
France
Related news from bioMérieux (Clinical Diagnostics)
- BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Mini Receives FDA Special Clearance and CLIA Waiver
- bioMérieux's AST System VITEK® REVEAL Achieves FDA 510(k) Clearance
- FDA Clearance and CLIA-waiver for bioMerieux's BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
- US FDA CLIA-waiver for BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
- BioFire Defense Partners With BARDA
- FDA Clearance and CLIA-waiver for Fast and Innovative BIOFIRE® SPOTFIRE® POC System
- MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
- VIDAS® KUBE™ - the Next-generation VIDAS® System Receives CE Marking
- FDA Breakthrough Device Designation for SPECIFIC REVEAL® Rapid AST System
- Added Medical Value with Urine Sample Results Up to 8 Hours Faster
- bioMérieux to Distribute Specific Diagnostics’ REVEAL Rapid AST System in Europe
- Enhanced BIOFIRE® Blood Culture Identification 2 (BCID2) Panel Submitted for FDA Clearance
- New FDA Clearance for VITEK® MS: Expanded ID for Challenging Pathogens
- PhenoMATRIX™ for WASPLab®: AI for Sample Interpretation & Sorting
- BIOFIRE® FILMARRAY® Pneumonia Panels Gain FDA clearance and CE Marking
- bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
- FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS
- FDA Clearance for BacT/ALERT® VIRTUO™ Fully Automated Blood Culture System
- bioMérieux Your Expert in Infectious Diseases at ECCMID 2017
- bioMérieux Awarded Multi-year Agreement with NHS for Bacterial Screening of Platelets